Billing code 19082: Breast biopsyMedicare rate & RVUs in Alaska
Reports percutaneous biopsy of an additional breast lesion sampled with stereotactic guidance during an encounter that includes the primary lesion biopsy.
Medicare pays $407.50 for 19082 in the office in Alaska (Alaska*). Which amount applies depends on the service address.
Medicare allowed amount for participating (non-QP) physicians, before deductible, coinsurance and claim adjustments. Not a patient’s bill or a hospital charge.
On this page 9 sections
What 19082 covers
This add-on code covers percutaneous needle sampling of an additional breast lesion using stereotactic imaging to guide the biopsy. A radiologist or breast surgeon typically performs the procedure in a breast imaging center, outpatient department, or office equipped for stereotactic biopsy. Localization-device placement and imaging of the specimen are included when performed. The additional lesion must be distinct from the lesion reported with the primary biopsy.
Report 19082 with 19081 for each additional lesion biopsied using stereotactic guidance; it is not reported by itself. Documentation should identify the separately sampled lesion and support stereotactic guidance, with separate specimen labeling or pathology identification when applicable. CMS treats 19082 as an add-on billed with a primary procedure, and its payment falls within that primary procedure's global period.
This summary was written with AI assistance from CMS physician fee schedule data and checked against the CMS billing rules shown here. Rates on this page come directly from CMS files.
19082 in Alaska*
| Payment locality | Office | Facility |
|---|---|---|
| Alaska* | $407.50 | $94.46 |
How the 19082 rate is calculated
Each of 19082’s three RVUs is multiplied by a geographic index (GPCI) for the payment locality, added up, and multiplied by the conversion factor. Drag the indexes or enter a ZIP to see what moves the rate.
How the rate is built · 19082
RVUs × geographic indexes × conversion factor
Swap in your local Medicare rate.
Work 1.61Practice expense 9.10Malpractice 0.17
All indexes start at 1.000 (the national rate). Enter a ZIP or drag a slider.
Payment rules and modifiers for 19082
The CMS indicators that decide how 19082 is paid alongside other services.
CMS payment indicators · 19082
Breast biopsy
| Rule | CMS value | What it means |
|---|---|---|
| Global period | ZZZ | Add-on code: falls within the primary procedure’s global period. |
| Multiple procedures | 0 | No multiple-procedure reduction. |
| Bilateral (modifier 50) | 0 | The 150% bilateral adjustment doesn’t apply. |
| Assistant at surgery (80/81/82/AS) | 0 | Not paid without supporting documentation. |
| Co-surgeons (62) | 0 | Not permitted. |
| Team surgery (66) | 0 | Not permitted. |
| Professional/technical | 0 | Physician service: no professional/technical split. |
19082 compared with similar codes
Compare codes
19082 vs 19081 vs 19084 vs 19086 vs 19083: national Medicare rates
Swap in your local Medicare rate.
How to choose
- 19081Breast biopsy
- 19081 reports the first lesion biopsied with stereotactic guidance; 19082 reports each additional lesion sampled with that guidance.
- 19084Breast biopsy
- Both are add-on codes for an additional lesion, but 19084 uses ultrasound guidance rather than stereotactic guidance.
- 19086Breast biopsy
- 19086 reports an additional lesion sampled with MRI guidance; 19082 is for stereotactic guidance.
- 19083Breast biopsy
- 19083 is the first-lesion code for ultrasound-guided biopsy. For an additional lesion, ultrasound guidance points to 19084 instead.
19082 billing questions
When should 19082 be reported instead of 19081?
Use 19081 for the first lesion biopsied with stereotactic guidance. Report 19082 for each additional distinct lesion sampled with that guidance.
Can 19082 be billed by itself?
No. It is an add-on code and must be reported with the primary stereotactic breast biopsy, 19081.
Can the localization device or specimen imaging be billed separately?
Device placement and imaging of the specimen are included when performed as part of the biopsy described by this code.
What documentation supports reporting an additional lesion?
Record that a distinct additional breast lesion was sampled, the use of stereotactic guidance, and the specimen identification for each sampled site.
How does 19082 differ from 19084?
Both report an additional lesion, but 19082 is for stereotactic guidance and 19084 is for ultrasound guidance.
Where these rates come from
FeeBase calculates base physician payments from CMS work, practice-expense and malpractice RVUs, adjusted by each locality’s geographic indexes and the conversion factor. Services without a published rate are labeled, never given a made-up amount. Amounts are Medicare allowed amounts before claim adjustments: not a patient’s bill or a commercial rate.
CMS RVU26D · effective Oct 1, 2026 through the day before Jan 1, 2027
Show the CMS file lines behind this rate
Fee sheets
Put 19082 and the rest of your codes on one sheet
Build a fee sheet from your own code list at your locality, put your payer contracts beside Medicare, and see what changed each quarter.
Build my fee sheetOr price your code list free →